Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
BioGraphene logo — Advance Graphene-Based Technology to Save and Improve People...

BioGraphene

Advance Graphene-Based Technology to Save and Improve People's Lives

Founded 2017 United States Los Angeles, United States 3 employees Venture round Biotechnology, Health Care +1

General Information

Company Name BioGraphene
Founded Year 2017
Location United States Los Angeles, United States
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with BioGraphene. To contact BioGraphene, visit bio-graphene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioGraphene compare?

A PDF of BioGraphene and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioGraphene soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioGraphene

BioGraphene is a biotech startup focused on revolutionizing the treatment of neurodegenerative diseases through advanced graphene-based drugs. The company's slogan "Advance Graphene-Based Technology to Save and Improve People's Lives" encapsulates its mission to make a meaningful impact on healthcare. Founded in 2017 and headquartered in the United States, BioGraphene is a spin-off from Seoul National University and officially established as a legal entity in California in June 2020. The company operates within the Biotechnology, Health Care, and Pharmaceutical sectors. In January 2021, BioGraphene secured a significant Venture Round investment from WONIK Investment Partners, signifying a crucial milestone in its growth trajectory. This financial backing not only provides the necessary resources for research and development but also serves as a vote of confidence from a prominent investor in the industry. BioGraphene's focus on addressing challenging conditions such as Parkinson's disease, Alzheimer's disease, and Niemann-Pick disease type C (NPC) positions the company as a potential game-changer in the field of neurodegenerative disease therapeutics.

Business keywords: Biotech startup, Graphene-based drugs, Neurodegenerative diseases, Parkinson's disease, Alzheimer's disease, Niemann-Pick disease type C, Spin-off company, Seoul National University, California, Biomedical applications, Nanomedicines, Lysosomal storage diseases, Rare diseases, Graphene technology, Nanotechnology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
WONIK Investment Partners
WONIK Investment Partners
01 Jan 2021

BioGraphene Alternatives & Competitors

View All Alternatives
BioGraphene vs
Perlara PBC
Perlara PBC

Perlara is a the first biotech PBC on a mission to codevelop drugs with highly motivated families ra...

Series A
14 employees
Biotechnology, Health and Wellness
BioGraphene vs
Neurotrope Inc.
Neurotrope Inc. United States

Developing a new approach to combating Alzheimer's disease and other neurodegenerative diseases.

Series A
3 employees
Biotechnology, Health Care
BioGraphene vs
ESCAPE Bio
ESCAPE Bio United States

A CLINICAL-STAGE COMPANY DEVELOPING NOVEL, PRECISELY TARGETED THERAPIES FOR GENETIC NEURODEGENERATIV...

Series B
6 employees
Biotechnology, Health Care
View all alternatives

FAQ About BioGraphene

Advance Graphene-Based Technology to Save and Improve People's Lives
BioGraphene was founded in 2017.
BioGraphene is headquartered in Los Angeles, United States.
BioGraphene operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Biotech startup, Graphene-based drugs, Neurodegenerative diseases and Parkinson's disease.
BioGraphene has approximately 3 employees.
BioGraphene has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to BioGraphene include Perlara PBC, Neurotrope Inc., ESCAPE Bio, Wren Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioGraphene and Perlara PBC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioGraphene, https://bouncewatch.com/company/biographene, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes